Patient Guide: A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06764316
Status: 🟢 Enrolling Now
Condition: Hepatocellular Carcinoma
Phase: PHASE1

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Kortrijk,
  • • Edmonton, Alberta
  • • Montreal, Quebec
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer - Join Clinical Trial NCTNCT06764316

How to Join This Clinical Trial - NCTNCT06764316

Learn how to participate in this PHASE1 trial studying an investigational therapy for Hepatocellular Carcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hepatocellular Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hepatocellular Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06764316 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Kortrijk, 8500 - Belgium

Status: RECRUITING

Clinical Research Site

Edmonton, Alberta T6G 1Z2 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Montreal, Quebec H2X 0A9 - Canada

Status: RECRUITING

Clinical Research Site

Montreal, Quebec H4A 3J1 - Canada

Status: RECRUITING

Clinical Research Site

Sherbrooke, Quebec J1H 5N4 - Canada

Status: RECRUITING

Clinical Research Site

Tampere, 33520 - Finland

Status: NOT_YET_RECRUITING

Clinical Research Site

Turku, 20540 - Finland

Status: RECRUITING

Clinical Research Site

Madrid, 28050 - Spain

Status: RECRUITING

Clinical Research Site

Sutton, Surrey SM2 5PT - United Kingdom

Status: NOT_YET_RECRUITING

Clinical Research Site

London, W12 0HS - United Kingdom

Status: NOT_YET_RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Hepatocellular Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships